A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in ...
Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...
In September, Vertex filed for Chapter 11 bankruptcy protection and accused Irving, Texas-based Matheson Tri-Gas Inc. of ...
Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
This was the stock's third consecutive day of gains.
We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are ...
CWA Asset Management Group LLC trimmed its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) ...
Vertex partners with Orna Therapeutics to develop in vivo gene editing treatments for sickle cell disease and beta ...
Vertex Global Services partners with Arish Global Services to create 5,000 jobs in Delhi-NCR, focusing on business process ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The artificial intelligence (AI) boom has taken the stock market by storm. Wall Street is currently fixated on AI agents, which differ slightly from traditional AI copilots. Alphabet (NASDAQ: GOOGL) ...